1-3 of 3
Shin Fujisawa
Close
Sort by
Journal Articles

Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis

Takashi Toya, Kota Mizuno, Masatoshi Sakurai, Jun Kato, Takehiko Mori, Noriko Doki, Shinichi Masuda, Nobuyuki Aotsuka, Shokichi Tsukamoto, Emiko Sakaida, Yuki Nakajima, Shin Fujisawa, Shinichiro Machida, Yasuyuki Aoyama, Hiroki Yokoyama, Katsuhiro Shono, Yoshihiro Hatta, Kensuke Usuki, Keisuke Kataoka, Yoshinobu Kanda
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1084–1093.
https://doi.org/10.1182/bloodadvances.2023010735
Published: 2024
Includes: Supplemental data
Journal Articles

Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia

Clinical Trials & Observations
Isamu Sugiura, Noriko Doki, Tomoko Hata, Ryuko Cho, Toshiro Ito, Youko Suehiro, Masatsugu Tanaka, Shinichi Kako, Mitsuhiro Matsuda, Hisayuki Yokoyama, Yuichi Ishikawa, Yasuhiro Taniguchi, Maki Hagihara, Yukiyasu Ozawa, Yasunori Ueda, Daiki Hirano, Toru Sakura, Masaaki Tsuji, Tsuyoshi Kamae, Hiroyuki Fujita, Nobuhiro Hiramoto, Masahiro Onoda, Shin Fujisawa, Yoshihiro Hatta, Nobuaki Dobashi, Satoshi Nishiwaki, Yoshiko Atsuta, Yukio Kobayashi, Fumihiko Hayakawa, Shigeki Ohtake, Tomoki Naoe, Yasushi Miyazaki
Journal: Blood Advances
Blood Adv (2022) 6 (2): 624–636.
https://doi.org/10.1182/bloodadvances.2021004607
Published: 2022
Journal Articles

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation

Clinical Trials & Observations
Koichi Miyamura, Kazunori Ohnishi, Shigeki Ohtake, Noriko Usui, Chiaki Nakaseko, Hiroyuki Fujita, Shin Fujisawa, Toru Sakura, Hirokazu Okumura, Noriyoshi Iriyama, Nobuhiko Emi, Katsumichi Fujimaki, Sumihisa Honda, Yasushi Miyazaki, Tomoki Naoe
Journal: Blood Advances
Blood Adv (2019) 3 (3): 312–319.
https://doi.org/10.1182/bloodadvances.2018025981
Published: 2019
Includes: Supplemental data